Scholar

The Lancet Diabetes Endocrinology

The Lancet is a weekly peer-reviewed general medical journal, founded in England in 1823. It is one of the world's… more

The Lancet Diabetes Endocrinology
H-index: 18
Public Health 32%
Business 22%
thelancetendo.bsky.social
Read our November Issue, featuring glucocorticoid-induced osteoporosis, obesity, metabolic syndrome, type 2 diabetes, cardiovascular disease, type 1 diabetes, medical education, older adults, & much more tinyurl.com/mwfu4c6m

#MedSky #EndoSky #RheumSky
thelancetendo.bsky.social
#Hyperprolactinaemia can result from dopamine antagonist drug effects and reduced prolactin clearance with liver or kidney disease with loss of feedback regulation thelancet.com/journals/lan...
#prolactinoma #pituitary #adenoma

#MedSky #EndoSky
thelancetendo.bsky.social
There is substantial heterogeneity in the contributors to the pathophysiology of #MASLD, which might influence its rate of progression, its relationship with #cardiometabolic diseases, and the response to therapy www.thelancet.com/journals/lan...
#OpenAccess

#MedSky #EndoSky #LiverSky #HepSky
lancetgastrohep.bsky.social
Our latest issue is out now at www.thelancet.com/gastrohep!

Content includes #obesity, #MASLD, #FMT for #Cdiff #viralhepatitis, #cirrhosis, #DGBI & more!

#GastroSky #LiverSky #MedSky
thelancet.com
The treatment of type 1 diabetes is entering a transformative era.

A recent Review explores three paradigm-shifting developments poised to transform type 1 diabetes treatment: tinyurl.com/2834ymk7
Figure showing the production and transplantation of β cells derived from embryonic or induced pluripotent stem cells. Copyright: 2025 The Author(s). Published by Elsevier Ltd. CC BY 4.0.
thelancetendo.bsky.social
As screening and early treatment for type 1 #diabetes become more widespread, the European action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease Interception (EDENT1FI) consortium highlights the need for clearer, more consistent terminology www.thelancet.com/journals/lan... #T1D
thelancet.com
Incretin-based therapies are becoming a core component of diabetes care.

By linking digestion, metabolism, & cardiovascular function, incretin-based therapies can help reduce morbidity & mortality.

Find out more in @thelancetendo.bsky.social: tinyurl.com/dvtv7j28
Figure showing effects of incretins on digestion and the possible resulting clinical benefits. Copyright: 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
thelancetendo.bsky.social
The implications of this trial, combined with existing evidence, suggest that #monlunabant has potential as a novel treatment option for people with #obesity and #metabolic #syndrome, if a safe and effective therapeutic window can be established www.thelancet.com/journals/lan...

#MedSky #EndoSky
thelancetendo.bsky.social
The evolutionary basis for type 2 #diabetes prevalence in the Arabian Peninsula www.thelancet.com/journals/lan... #T2D

#MedSky #EndoSky
thelancet.com
Tune in on October 3rd for the official launch of the 2025 EAT-Lancet Commission. A major update to the science and what it means for our global food system.

🔗 Register for the livestream here: bit.ly/3Kg9SW8
A promotional card for the 2025 EAT-Lancet Commission, officially launching on October 3 at Stockholm Food Forum.

References

Fields & subjects

Updated 1m